Clinical trial
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal…
NCT00068692 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00068692 |
|---|---|
| Title | Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer |
| Official title | Intergroup Randomized Phase III Study of Postoperative Irinotecan, 5-Fluorouracil and Leucovorin vs. Oxaliplatin, 5-Fluorouracil and Leucovorin vs. 5-Fluorouracil and Leucovorin for Patients With Stage II or III Rectal Cancer Receiving Either Preoperative Radiation and 5-Fluorouracil or… |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma, Stage IIA Rectal Cancer AJCC v7, Stage IIB Rectal Cancer AJCC v7, Stage IIC Rectal Cancer AJCC v7, Stage IIIA Rectal Cancer AJCC v7, Stage IIIB Rectal Cancer AJCC v7, Stage IIIC Rectal Cancer AJCC v7, Stage IVA Rectal Cancer AJCC v7 and 1 more |
| Intervention type | Drug, Radiation |
| Interventions | Radiotherapy, Fluorouracil, Leucovorin Calcium, Oxaliplatin, Irinotecan |
| Enrollment | 225 |
| Start date | Oct 15, 2003 |
| Primary completion | Nov 15, 2016 |
| Completion | Nov 15, 2016 |
| First posted | Sep 11, 2003 |
| Last update posted | Dec 4, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: